Lupin Receives US FDA EIR for Ankleshwar Manufacturing Site
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
BUBENDORF, Switzerland, May 6, 2026 CARBOGEN AMCIS, a global pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company,...
NEW YORK, NY, May 1, 2026 SK Capital Partners, LP announced the successful completion of the sale of Noramco...
MENLO PARK, CA — November 20, 2025 — Antheia announced a strategic partnership with TAPI (Teva Active Pharmaceutical Ingredients)...
Norwood, Massachusetts – October 31, 2025 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), an oncology and obesity-focused biotechnology company,...
TOKYO, Japan – October 31, 2025 — Nxera Pharma Co., Ltd. announced that its subsidiary, Nxera Pharma Japan, has...
